Conventional Medical Therapies

Treatments for Pulmonary Hypertension

Issued by PHA’s Scientific Leadership Council
Last Updated June 2005

Calcium channel blockers (CCBs)

What are calcium channel blockers?

(CCBs) and how do they work? CCBs are oral medications which relax the muscles around blood vessels allowing for better blood flow through the blood vessels. They also have effects on the electrical system of the heart and can be useful in slowing or regulating fast heart rates. They are often used in the treatment of systemic hypertension. Although no randomized clinical trials have been performed in patients with PAH, CCBs have been used to treat PAH for over 25 years.

How are CCBs given?

CCBs are pills which are taken by mouth. Depending on the specific medication and the dose, they may be taken from one to three times a day. Some CCBs come in intravenous form as well and are used in hospitalized patients to control heart rate and blood pressure. The CCBs used most frequently in patients with PAH are nifedipine, diltiazem or amlodopine. While early studies supported more widespread use of CCBs for treatment of PAH, it now appears that they are beneficial in only a small subset of PAH patients (less than 10%). The subset of patients with PAH who may benefit from CCBs are those who have undergone vasodilator testing during right heart catheterization and have demonstrated a very good response.

What are the major problems with calcium channel blockers?

Early recommendations once favored relatively high doses of CCBs in patients with PAH but many experts now agree that these medicines should be introduced more cautiously and the dose increased only as tolerated. Patients with PAH with severe right heart failure should not use CCBs. Verapamil, a CCB which can depress heart function, should not be used in patients with PAH. Patients with PAH receiving CCBs should be monitored closely to determine the safety and efficacy of the therapy. Side effects can include dizziness, low blood pressure, and fluid retention.

How do patients obtain calcium channel blockers?

CCBs must be prescribed by a physician and can be obtained at any pharmacy. All insurance pays for CCBs.

Digoxin

What is digoxin and how does it work?

Digoxin is a drug which may assist the pumping of the heart. Digoxin also modulates the electrical activity in the heart. The use of digoxin in PAH has not been very well studied but it is sometimes used to help manage heart failure and/or control irregular heart beats.

How is digoxin given?

Digoxin is a pill which is taken by mouth once a day.

What are the major problems with digoxin?

Digoxin has a very narrow therapeutic range. It can cause irregular heart rhythms, nausea and changes in vision, especially when levels in the blood are increased. Digoxin can interact with other medications. A blood test to determine levels of digoxin can help determine the appropriate dose for each patient and help to avoid side effects.

How do patients obtain digoxin?

Digoxin must be prescribed by a physician and can be obtained at any pharmacy. All insurance pays for digoxin.

Warfarin (Coumadin®)

What is warfarin and how does it work?

Warfarin is a drug that "thins" the blood and prevents it from clotting normally. It has been shown that blood clots can occur in some patients with PAH and may contribute to their disease. Warfarin has not been well studied in PAH but uncontrolled studies suggest that it may be helpful for patients with idiopathic PAH. It is unknown whether this advantage (if any) outweighs the risk of bleeding complications. Use of warfarin in other diseases associated with the development of PAH has not been studied. Warfarin therapy should be considered in PAH patients treated with intravenous epoprostenol or intravenous treprostinil as it may help prevent clots from forming in their catheters.

How is warfarin given?

Warfarin is a pill which is taken by mouth once a day.

What are the major problems with warfarin?

Warfarin can be associated with excessive bleeding since it prevents blood from clotting normally. It interacts with many other medications, and many foods can either increase or decrease its effect. Blood tests to measure an INR (International Normalized Ratio) are required to monitor the effect of warfarin on blood clotting. This is usually obtained weekly when patients first begin warfarin therapy and then monthly once they reach a stable dose. There is no consensus as to what degree of anticoagulation is appropriate for patients with PAH, but most experts target an INR of 1.5 to 2.5. Warfarin can cause serious birth defects and should not be taken by women who are pregnant or who may become pregnant.

How do patients obtain coumadin?

Warfarin must be prescribed by a physician and can be obtained at any pharmacy. All insurance pays for warfarin.

Diuretics

What are diuretics and how do they work?

Diuretics are medicines which help treat heart failure and fluid retention (from heart failure and/or side effect of CCB). They work by stimulating the kidneys to increase urine output. There are several different types of diuretics and they come in pill and intravenous form.

How are diuretics given?

Diuretics are taken one to two times a day by mouth. Diuretics are used in PAH patients with or without evidence of heart failure (e.g. swelling in the legs, fluid in the abdomen). Diuretics, along with careful attention to salt and fluid intake, help maintain the proper amount of fluid in the circulation.

What are the major problems with diuretics?

Rapid or excessive use of diuretics can lead to dehydration, low blood pressure, chemical imbalances in the blood, and problems with kidney function. Blood tests to monitor chemistry and kidney function should be obtained regularly in patients receiving diuretic therapy.

How do patients obtain diuretics?

Diuretics must be prescribed by a physician and can be obtained at any pharmacy. All insurance pays for diuretics.

Oxygen

What is oxygen and how does it work?

Oxygen is required for life and is a component of the air we breathe. Low oxygen levels can cause pulmonary blood vessels to constrict (narrow) and this may worsen PAH. It is best to maintain an oxygen saturation of at least 90% or higher in patients with PAH when and if possible. This can be achieved in most patients by supplemental oxygen therapy.

How is oxygen given?

Supplemental oxygen is supplied in tanks which must be prepared and delivered by an oxygen supply company. The oxygen is inhaled by patients via a nasal cannula or a face mask which is attached to the oxygen tank by plastic tubing. At home, patients use a machine called a condenser which supplies oxygen indefinitely, although it requires electricity to work. When patients are outside of the home, oxygen is supplied by portable tanks that last for a few hours only, depending upon how much oxygen is required. The rate at which oxygen is set to flow varies from patient to patient and is prescribed by a physician. Usual flow rates range from 1-6 liters/min.

What are the major problems with oxygen therapy?

Depending on the flow rate, oxygen delivered via nasal cannula can cause dryness in the nose which can lead to irritation and occasionally nosebleeds. Humidification of the oxygen minimizes this problem. While it can be bulky and may last only a few hours, portable oxygen allows patients to use oxygen while going about their normal activities outside of the home.

How do patients obtain oxygen therapy?

Oxygen therapy must be prescribed by a physician. Insurers generally require that patients have a measurement of blood oxygen to qualify them for therapy before they will provide it.

The information provided on the PHA website is provided for general information only. It is not intended as legal, medical or other professional advice, and should not be relied upon as a substitute for consultations with qualified professionals who are familiar with your individual needs.

801 Roeder Road, Ste. 1000, Silver Spring, MD 20910   Patient-to-Patient Support Line: 1-800-748-7274
Webmaster@PHAssociation.org
    Privacy Policy   Virtual Tour of Website    Provide Feedback & Report Bugs

Designed by Matrix Group International, Inc.® | © 2014 Pulmonary Hypertension Association. All Rights Reserved.

NORD

The National Organization for Rare Disorders (NORD) awarded PHA the Abbey S. Meyers Leadership Award in 2012 for outstanding service to PHA members in advocacy, education and other key areas.